StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Revenue Recognized from Prior-Period Completed Tests by Quarter

Revenue Recognized from Prior-Period Completed Tests — Cash Collection True-Ups ($M) ($M)

Natera Revenue Recognized from Prior-Period Completed Tests: $52.3M in Q2 2026, up 15.5% from a year earlier.

Latest, Q2 2026
52.3
Period ended Jun 30, 2026
Change on a year earlier
+15.5%
45.3 in Q2 2025
History
14 quarters
Since Q1 2023
Sources
9
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (2026-08-07) ↗

Revenue recognized in the current period from cash collections and appeal recoveries exceeding prior variable consideration estimates for tests completed in prior periods ($52.3M or $0.36/sh in Q2 2026; $161.3M or $1.18/sh in FY2025).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRevenue Recognized from Prior-Period Completed Tests — Cash Collection True-Ups ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202652.3+15.5%Form 10-Q (2026-08-07) ↗
Q1 2026Mar 31, 202661+77.8%Form 10-Q (2026-05-08) ↗
Q4 2025Dec 31, 202559.7+38.5%Form 10-K (2026-02-27) ↗
Q3 2025Sep 30, 202555.1+59.7%Form 10-Q (2025-11-07) ↗
Q2 2025Jun 30, 202545.3+13.5%Form 10-Q (2026-08-07) ↗
Q1 2025Mar 31, 202534.3+1.8%Form 10-Q (2026-05-08) ↗
Q4 2024Dec 31, 202443.1+378.9%Form 10-K (2026-02-27) ↗
Q3 2024Sep 30, 202434.5+1,468.2%Form 10-Q (2025-11-07) ↗
Q2 2024Jun 30, 202439.9+1,073.5%Form 10-Q (2025-08-08) ↗
Q1 2024Mar 31, 202433.7-466.3%Form 10-Q (2025-05-09) ↗
Q4 2023Dec 31, 20239–Form 10-K (2026-02-27) ↗
Q3 2023Sep 30, 20232.20–Form 10-Q (2024-11-12) ↗
Q2 2023Jun 30, 20233.40–Form 10-Q (2024-08-09) ↗
Q1 2023Mar 31, 2023-9.20–Form 10-Q (2024-05-10) ↗

Breakdown

What makes up revenue Recognized from Prior-Period Completed Tests

Cite this data

StockData. (2026). Natera Revenue Recognized from Prior-Period Completed Tests ($M), quarterly Q1 2023–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-prior-period-trueup

See every metric in the Natera KPI table. Data updated Nov 2, 2026.